Home › Funds › Birchview Capital, LP › PRTA

Birchview Capital, LP position in PRTA

PROTHENA CORP PLC · Health Care

Birchview Capital, LP reported holding 449,019 shares of PRTA (PROTHENA CORP PLC) in its Q3 2026 13F filing — a position valued at US$3.8M, representing 2.24% of its reported portfolio and ranking #10 among its reported holdings. Birchview Capital, LP has disclosed PRTA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)449.02K sh
Reported value held$3.76M
Portfolio Weight2.24%
First reportedQ3 2023
Last changeHold
Updated2026-11-14

Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR

How Birchview Capital, LP's PRTA position evolved

Birchview Capital, LP first disclosed a stake in PRTA in Q3 2023 at 169,574 shares (US$8.2M). Across 13 filings, Birchview Capital, LP increased the stake 7 time(s), trimmed it 1 time(s) and left it unchanged 4 time(s). The most recent filing (Q3 2026) shows 449,019 shares valued at US$3.8M. Notable position changes include a 45% increase in Q4 2024 (shares fell 11% over the following quarter), a 35% increase in Q2 2025 (shares rose 61% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 169.57K $8.18M New
Q4 2023 169.57K $6.16M Hold
Q1 2024 169.57K $4.20M Hold
Q2 2024 203.57K $4.20M Add
Q3 2024 209.57K $3.51M Add
Q4 2024 304.57K $4.22M Add
Q1 2025 332.97K $4.12M Add
Q2 2025 451.02K $2.74M Add
Q3 2025 549.02K $5.36M Add
Q4 2025 441.02K $4.21M Reduce
Q1 2026 449.02K $4.36M Add
Q2 2026 449.02K $4.40M Hold
Q3 2026 449.02K $3.76M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PRTA and 13F data

PRTA (PROTHENA CORP PLC) is a Health Care company. 17 other funds we track also report a position in PRTA — the largest reported positions include ADAR1 Capital Management, LLC (US$15.2M), Palo Alto Investors LP (US$11.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PRTA

All PRTA fund holders →

FAQ

How long has Birchview Capital, LP held PRTA?

Birchview Capital, LP has disclosed PRTA holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Birchview Capital, LP's current position in PRTA?

As of Q3 2026, Birchview Capital, LP holds 449.02K shares of PRTA (PROTHENA CORP PLC), valued at $3.76M, representing 2.24% of its reported portfolio and ranking #10.

Has Birchview Capital, LP been buying or selling PRTA?

In the latest 13F filing (Q3 2026), Birchview Capital, LP held unchanged its position in PRTA.

Which other funds hold PRTA?

Other major institutional holders of PRTA include ADAR1 Capital Management, LLC, Palo Alto Investors LP, among 17 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.